OBGC
CL icon

O'Brien Greene & Co’s Colgate-Palmolive CL Stock Holding History

O'Brien Greene & Co’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$654K Hold
7,675
– – 0.19% 81
2025
Q4 		$606K Sell
7,675
-350
-4% -$27.4K 0.18% 76
2025
Q3 		$642K Sell
8,025
-1,017
-11% -$86.8K 0.2% 72
2025
Q2 		$822K Hold
9,042
– – 0.27% 61
2025
Q1 		$847K Hold
9,042
– – 0.28% 54
2024
Q4 		$822K Buy
9,042
+42
+0.5% +$4.01K 0.27% 61
2024
Q3 		$934K Sell
9,000
-42
-0.5% -$4.28K 0.29% 59
2024
Q2 		$877K Buy
9,042
+42
+0.5% +$3.87K 0.28% 59
2024
Q1 		$810K Hold
9,000
– – 0.27% 65
2023
Q4 		$717K Hold
9,000
– – 0.25% 67
2023
Q3 		$640K Sell
9,000
-250
-3% -$18.7K 0.23% 66
2023
Q2 		$712K Hold
9,250
– – 0.25% 64
2023
Q1 		$695K Sell
9,250
-250
-3% -$18.6K 0.26% 63
2022
Q4 		$748K Sell
9,500
-21,319
-69% -$1.6M 0.28% 58
2022
Q3 		$2.17M Buy
30,819
+20,546
+200% +$1.61M 0.29% 58
2022
Q2 		$823K Hold
10,273
– – 0.31% 53
2022
Q1 		$779K Sell
10,273
-6
-0.1% -$475 0.26% 65
2021
Q4 		$877K Buy
10,279
+71
+0.7% +$5.54K 0.29% 64
2021
Q3 		$771K Buy
10,208
+8
+0.1% +$635 0.28% 67
2021
Q2 		$829K Buy
10,200
+1,700
+20% +$139K 0.3% 63
2021
Q1 		$670K Hold
8,500
– – 0.27% 71
2020
Q4 		$726K Hold
8,500
– – 0.3% 66
2020
Q3 		$656K Hold
8,500
– – 0.31% 64
2020
Q2 		$622K Hold
8,500
– – 0.33% 63
2020
Q1 		$564K Hold
8,500
– – 0.38% 59
2019
Q4 		$586K Hold
8,500
– – 0.3% 73
2019
Q3 		$624K Hold
8,500
– – 0.33% 68
2019
Q2 		$610K Sell
8,500
-400
-4% -$28.4K 0.32% 70
2019
Q1 		$610K Hold
8,900
– – 0.31% 73
2018
Q4 		$530K Buy
+8,900
New +$557K 0.32% 63

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

O'Brien Greene & Co's CL Position: Q1 2026 in Review

O'Brien Greene & Co held its Colgate-Palmolive (CL) position steady in Q1 2026 at 7,675 shares worth $654K. The position accounts for 0.19% of the portfolio, ranked #81.

O'Brien Greene & Co first reported a position in CL in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.17M in Q3 2022. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • O'Brien Greene & Co held 7,675 shares of Colgate-Palmolive worth $654K as of Q1 2026.
  • O'Brien Greene & Co left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.19% of O'Brien Greene & Co's portfolio in Q1 2026, its #81 holding.
  • O'Brien Greene & Co first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 30 quarters since.
  • O'Brien Greene & Co's Colgate-Palmolive position peaked at $2.17M in Q3 2022.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.